5,8,11,14-eicosatetraynoic acid and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine

5,8,11,14-eicosatetraynoic acid has been researched along with 1-hexadecyl-2-acetyl-glycero-3-phosphocholine in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19909 (90.00)18.7374
1990's0 (0.00)18.2507
2000's1 (10.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anderson, GP; Fennessy, MR1
Niwa, Y; Ohashi, T; Ozaki, Y1
Finiasz, M; Gimeno, M; Lazzari, MA; Schattner, MA1
Cassina, G; Livio, M; Macconi, D; Morelli, C; Morzenti, G; Remuzzi, G1
Benveniste, J; Hadji, L; Mencia-Huerta, JM1
Gorman, RR; Lin, AH; Morton, DR1
Ford-Hutchinson, AW1
O'Flaherty, JT; Stimler, NP1
Bowman, BJ; Smith, RJ1
Evanson, OA; Weiss, DJ1

Other Studies

10 other study(ies) available for 5,8,11,14-eicosatetraynoic acid and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine

ArticleYear
Lipoxygenase metabolites mediate increased airways responsiveness to histamine after acute platelet activating factor exposure in the guinea-pig.
    Agents and actions, 1988, Volume: 24, Issue:1-2

    Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; 5,8,11,14-Eicosatetraynoic Acid; Airway Resistance; Animals; Aspirin; Bronchi; Chromones; Female; Guinea Pigs; Histamine; Leukotriene B4; Lipoxygenase; Lung Compliance; Male; Platelet Activating Factor; Pyrazoles; Quinolinium Compounds; SRS-A

1988
A comparative study on the effects of inhibitors of the lipoxygenase pathway on neutrophil function. Inhibitory effects on neutrophil function may not be attributed to inhibition of the lipoxygenase pathway.
    Biochemical pharmacology, 1986, Oct-15, Volume: 35, Issue:20

    Topics: 5,8,11,14-Eicosatetraynoic Acid; Benzoquinones; Calcimycin; Chemotaxis, Leukocyte; Epoprostenol; Humans; Hydroxides; Hydroxyl Radical; Leukotriene B4; Lipoxygenase Inhibitors; Masoprocol; N-Formylmethionine Leucyl-Phenylalanine; NADH, NADPH Oxidoreductases; NADPH Oxidases; Neutrophils; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Quinones; Tetradecanoylphorbol Acetate; Umbelliferones

1986
Platelet aggregating substance from mononuclear leukocytes.
    Prostaglandins, leukotrienes, and medicine, 1986, Volume: 22, Issue:3

    Topics: 5,8,11,14-Eicosatetraynoic Acid; Adult; Arachidonic Acid; Arachidonic Acids; Aspirin; Blood Coagulation Factors; Catechols; Humans; In Vitro Techniques; Masoprocol; Monocytes; Platelet Activating Factor; Platelet Aggregation

1986
Acetyl glycerylphosphorylcholine aggregates human platelets through two distinct pathways, both dependent on arachidonic acid metabolism.
    Laboratory investigation; a journal of technical methods and pathology, 1985, Volume: 52, Issue:2

    Topics: 5,8,11,14-Eicosatetraynoic Acid; Arachidonic Acid; Arachidonic Acids; Aspirin; Blood Platelets; Catechols; Chromatography, Thin Layer; Cyclooxygenase Inhibitors; Humans; Imidazoles; In Vitro Techniques; Lipoxygenase Inhibitors; Masoprocol; Phospholipases; Platelet Activating Factor; Platelet Aggregation; Prostanoic Acids; Quinacrine; Radioimmunoassay; Receptors, Prostaglandin; Receptors, Thromboxane; Thromboxane A2; Thromboxane-A Synthase

1985
Release of a slow-reacting substance from rabbit platelets.
    The Journal of clinical investigation, 1981, Volume: 68, Issue:6

    Topics: 5,8,11,14-Eicosatetraynoic Acid; Adenosine Diphosphate; Animals; Arachidonic Acids; Aspirin; Autacoids; Blood Platelets; Chromatography, High Pressure Liquid; Cysteine; Indomethacin; Kinetics; Lysophosphatidylcholines; Platelet Activating Factor; Platelet Aggregation; Rabbits; Thrombin

1981
Acetyl glyceryl ether phosphorylcholine stimulates leukotriene B4 synthesis in human polymorphonuclear leukocytes.
    The Journal of clinical investigation, 1982, Volume: 70, Issue:5

    Topics: 5,8,11,14-Eicosatetraynoic Acid; Catechols; Cell Aggregation; Chromatography, Gas; Dose-Response Relationship, Drug; Humans; Leukotriene B4; Masoprocol; Mass Spectrometry; Neutrophils; Platelet Activating Factor

1982
Neutrophil aggregating properties of PAF-acether and leukotriene B4.
    International journal of immunopharmacology, 1983, Volume: 5, Issue:1

    Topics: 5,8,11,14-Eicosatetraynoic Acid; Animals; Catechols; Cell Aggregation; Dose-Response Relationship, Drug; Indomethacin; Leukotriene B4; Male; Masoprocol; Neutrophils; Platelet Activating Factor; Platelet Aggregation; Rabbits; Rats; Rats, Inbred Strains; Stimulation, Chemical

1983
Spasmogenic properties of platelet-activating factor: evidence for a direct mechanism in the contractile response of pulmonary tissues.
    The American journal of pathology, 1983, Volume: 113, Issue:1

    Topics: 5,8,11,14-Eicosatetraynoic Acid; Animals; Aspirin; Blood Platelets; Catechols; Chromones; Dose-Response Relationship, Drug; Guinea Pigs; Indomethacin; Lung; Masoprocol; Muscle Contraction; Muscle, Smooth; Platelet Activating Factor; Rats; Sulfinpyrazone; Thromboxane B2

1983
Stimulation of human neutrophil degranulation with 1-O-octadecyl-2-O-acetyl-SN-glyceryl-3-phosphorylcholine: modulation by inhibitors of arachidonic acid metabolism.
    Biochemical and biophysical research communications, 1982, Feb-26, Volume: 104, Issue:4

    Topics: 5,8,11,14-Eicosatetraynoic Acid; Calcium; Catechols; Cyclooxygenase Inhibitors; Cytochalasin B; Cytoplasmic Granules; Humans; Lipoxygenase Inhibitors; Lysophosphatidylcholines; Masoprocol; Muramidase; Neutrophils; Platelet Activating Factor

1982
Evaluation of lipopolysaccharide-induced activation of equine neutrophils.
    American journal of veterinary research, 2002, Volume: 63, Issue:6

    Topics: 5,8,11,14-Eicosatetraynoic Acid; Animals; Azepines; CD11 Antigens; CD18 Antigens; Cell Degranulation; Complement System Proteins; Cyclooxygenase Inhibitors; Enzyme Inhibitors; Flow Cytometry; Horses; Interleukin-8; Lipopolysaccharides; Neutrophil Activation; Neutrophils; Pentoxifylline; Platelet Activating Factor; Platelet Aggregation Inhibitors; Triazoles; Tumor Necrosis Factor-alpha

2002